Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Iridium Aqua Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102119165A introduces stable chiral iridium catalysts for asymmetric transfer hydrogenation in water, offering safer and greener pharmaceutical intermediate manufacturing.